Post-approval studies (Phase 4)Study completedNCT03948191What this trial is testing99Tc-MDP for Thyroid-Associated OphthalmopathyWho this might be right forThyroid-Associated Ophthalmopathy Dalian University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06088979What this trial is testingInvestigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease Tourmaline Bio, Inc., a Novartis Company 79
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603What this trial is testingClinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 StudyWho this might be right forGraves' Orbitopathy University of Pisa 102
Very early researchLooking for participantsNCT07129642What this trial is testingAllogeneic Anti-CD19 CAR-T for Refractory Graves' DiseaseWho this might be right forGraves Disease Shanghai Zhongshan Hospital 5
Post-approval studies (Phase 4)Study completedNCT00917241What this trial is testingPrevention Relapse of Graves' Disease by Intrathyroid Injection of DexamethasoneWho this might be right forGraves' Disease Xiao-Ming Mao 218
Large-scale testing (Phase 3)Study completedNCT06269393What this trial is testingIBI311 in Subjects With Steroid-resistant, Thyroid Associated OphthalmopathyWho this might be right forThyroid Associated Ophthalmopathy Peking University People's Hospital 53
Not applicableStudy completedNCT05945784What this trial is testingExploring Accessible Beauty for Individuals With Upper Extremity DeficitsWho this might be right forStroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more Casa Colina Hospital and Centers for Healthcare 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT07622121What this trial is testingTreatment of Chronic Thyroid Eye Disease With MHB018AWho this might be right forThyroid Eye Disease, TED Minghui Pharmaceutical (Hangzhou) Ltd 135
Testing effectiveness (Phase 2)Ended earlyNCT03938545What this trial is testingASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO )Who this might be right forGraves' Ophthalmopathy (GO) Immunovant Sciences GmbH 65
Not applicableStudy completedNCT03009357What this trial is testingClinical Application of Pulse Rate-monitoring Activity Trackers in ThyrotoxicosisWho this might be right forThyrotoxicosisGraves DiseaseThyroiditis Seoul National University Bundang Hospital 40
Not applicableLooking for participantsNCT07381413What this trial is testingEye Tracking Study on Eye Movement Function and Visual Attention Patterns in Patients With Thyroid-Associated OphthalmopathyWho this might be right forThyroid Associated OphthalmopathiesEye Tracking Shanghai Changzheng Hospital 100
Not applicableStudy completedNCT03590080What this trial is testingImpact of Intravenous Methylprednisolone Treatment on Blood PressureWho this might be right forGraves DiseaseGraves OphthalmopathyHypertension+2 more Medical University of Warsaw 32
Large-scale testing (Phase 3)Study completedNCT05176639What this trial is testingA Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 113
Large-scale testing (Phase 3)Not Yet RecruitingNCT07620405What this trial is testingOpen-Label Extension Study of MHB018A in Patients With Thyroid Eye DiseaseWho this might be right forThyroid Eye Disease (TED) Minghui Pharmaceutical (Hangzhou) Ltd 219
Large-scale testing (Phase 3)Study completedNCT06179875What this trial is testingAn Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 139
Large-scale testing (Phase 3)Study completedNCT07155668What this trial is testingA Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)Who this might be right forThyroid Eye Disease Viridian Therapeutics, Inc. 87
Post-approval studies (Phase 4)Study completedNCT01458600What this trial is testingAdjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)Who this might be right forGraves´ Disease Mikael Lantz 65
Not applicableStudy completedNCT00432146What this trial is testingEffect of Lugol's Solution in the Patients With Graves' DiseaseWho this might be right forGraves Disease Istanbul University 36
Post-approval studies (Phase 4)Study completedNCT00946296What this trial is testingImpact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves DiseaseWho this might be right forGraves DiseaseHyperthyroidism University of Massachusetts, Worcester 36
Not applicableNot Yet RecruitingNCT07623837What this trial is testingClinical Validation of AI-Based Quantitative Eye Movement Analysis From Smartphone 9-Gaze Videos (Glandy EOM)Who this might be right forOcular Motility DisordersStrabismusExtraocular Muscle Dysfunction+1 more THYROSCOPE INC. 1,000